Somaia E. Elsheikh

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Somaia E Elsheikh, Somaia Elbauomy Elsheikh, Somaia Elsheikh
Publication record
35 papers · 2,092 citations · H-index 18

PAPERS

CPC10 An unusual case of bilateral periorbital lesions
20230 citationsauthor #4
Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis
202221 citationsauthor #4
CPC07: Erythromelalgia associated with small‐fibre neuropathy
20221 citationsauthor #7
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy
202192 citationsauthor #10
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
202035 citationsauthor #6
T FR Cells Inhibit Anti-Tumor Immunity and are Responsive to Immune Checkpoint Blockade
20201 citationsauthor #10
Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma
20200 citationsauthor #6
Ran GTPase is an independent prognostic marker in malignant melanoma which promotes tumour cell migration and invasion
20206 citationsauthor #1
Immune-Instructive Polymers Control Macrophage Phenotype and Modulate the Foreign Body Response In Vivo
202096 citationsauthor #14
Development and Initial Validation of Calculated Tumor Area as a Prognostic Tool in Cutaneous Malignant Melanoma.
201920 citationsauthor #3
Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study
201921 citationsauthor #10
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
201838 citationsauthor #7
Multimodal Spectral Histopathology for Detection of Residual Tumour during Basal Cell Carcinoma Surgery
20180 citationsauthor #7
Automated multimodal spectral histopathology for quantitative diagnosis of residual tumour during basal cell carcinoma surgery
201728 citationsauthor #7
Factors Influence Lymph Node Retrieval after Resection for Rectal Cancer
20161 citationsauthor #1
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
2016112 citationsauthor #4
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
2016112 citationsauthor #5
An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study).
201319 citationsauthor #8
Growth fraction as a predictor of response to chemotherapy in node‐negative breast cancer
201044 citationsauthor #5
O-88 Breast cancer among Nigerian women: Clinical and biological differences compared with age-matched UK women
20101 citationsauthor #4
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
2009500 citationsauthor #2
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
2009460 citationsauthor #1
162 Altered Histone Modifications and their regulating enzymes in Fulvestrant resistant breast cancer cell line In Vitro [Abstract]
20090 citationsauthor #1
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
200870 citationsauthor #3
CAV1 and CAV2 are associated with breast cancer basal-like and triple negative immunophenotype
200810 citationsauthor #1
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
2008156 citationsauthor #1
Prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT
20082 citationsauthor #5
Role of lymph vessels in progression of breast cancer; morphological characteristics and prognostic implication
20080 citationsauthor #2
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome
2008158 citationsauthor #1
O-80 CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome
20071 citationsauthor #1
O-90 Prognostic significance of vascular endothelial cell growth factor (VEGF) -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis
20073 citationsauthor #3
O-43 Global histone modifications in breast cancer tissue correlate with tumor phenotype, prognostic factors and patient outcome
20070 citationsauthor #1
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.
200784 citationsauthor #7
O-92 UPARAP/ENDO180 expression in invasive breast carcinoma and its relation to patient outcome
20070 citationsauthor #1
Modified histones in breast cancer and their prognostic significance
20060 citationsauthor #1

TIMELINE

2006 0 citations

2007 88 citations

2008 396 citations

2009 960 citations

2010 45 citations

2013 19 citations

2016 113 citations

2017 28 citations

2018 38 citations

2019 41 citations

2020 138 citations

2021 92 citations

2022 22 citations

2023 0 citations

Somaia E. Elsheikh

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT